Health UnaBASHEd: BIO 2026 China, Clinical Trials, and California's Moment of Reckoning

Recorded live from BIO 2026 in San Diego, Gil sits down with Sam Chung, Senior Vice President of Government Relations and External Affairs at California Life Sciences (CLS), to examine a stark and urgent question: Is America's leadership in biomedical innovation still a given? Against the backdrop of NIH funding cuts, a 34% drop in San Diego venture capital, California's post-2030 R&D tax credit rollback, and China's explicit, government-backed commitment to dominating the global life sciences sector, Chung delivers a data-driven, candid, and at times sobering assessment of the headwinds threatening what he calls the "crown jewel" of the California economy. The conversation covers clinical trial timelines, IP migration, talent flight, and what policymakers at both the state and federal level must do to preserve American biomedical leadership before it becomes a historical footnote. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen